Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9402844 Methods of modulating drug plasma levels using erythrohydroxybupropion

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
February 20, 2015
Date of Patent
August 2, 2016
Patent Application Number
14628062
Patent Citations Received
‌
US Patent 12109178 Bupropion as a modulator of drug activity
0
‌
US Patent 11969421 Bupropion as a modulator of drug activity
0
‌
US Patent 11986444 Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
0
‌
US Patent 11752144 Compounds and combinations thereof for treating neurological and psychiatric conditions
‌
US Patent 11779579 Bupropion as a modulator of drug activity
‌
US Patent 11839612 Compounds and combinations thereof for treating neurological and psychiatric conditions
0
‌
US Patent 11883373 Treatment of depression in certain patient populations
0
‌
US Patent 11925636 Bupropion dosage forms with reduced food and alcohol dosing effects
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9402844
Patent Primary Examiner
‌
Jared D Barsky

Find more entities like US Patent 9402844 Methods of modulating drug plasma levels using erythrohydroxybupropion

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo